Management of STEMI (ST-Elevation Acute Myocardial Infarction)
ECG & Echo Learning
JANUARY 18, 2023
I C Glucose-lowering therapy should be considered in ACS patients with glucose levels >10 mmol/L (>180 mg/dL), while episodes of hypoglycaemia (defined as glucose levels <_3.9 I C In patients on metformin and/or SGLT2 inhibitors, renal function should be monitored for at least 3 days after angiography.
Let's personalize your content